Results 201 to 210 of about 57,246 (250)

Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection

Vaccine, 1997
Patients on hemodialysis therapy are at a relatively high risk of exposure to hepatitis B virus (HBV) infection. The prevalence of hepatitis C virus (HCV) infection is even higher and was reported as 33.2% in Taiwan. Although the efficacy of hepatitis B vaccine was well documented, the vaccination schedule in hemodialysis patients is not clearly ...
Ping-Chin Lai, Chiu-Ching Huang
exaly   +3 more sources

An inactivated hepatitis A viral vaccine of cell culture origin

Journal of Medical Virology, 1986
AbstractHepatitis A virus (HAV) strain CR326, adapted to grow in LLC‐MK2 cells, was highly purified, inactivated with formalin, adsorbed to alum, and tested for capacity to induce antibody to HAV in both mice and marmosets. The minimum dose of HAV antigen necessary to produce antibody in 50% of mice was 10 ng.
P J Provost, E A Emini, W J Miller
exaly   +3 more sources

Viral Hepatitis Vaccines

Annual Review of Medicine, 1985
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed.
I M, Jacobson, J L, Dienstag
openaire   +3 more sources

Vaccines for prevention of viral hepatitis

Haemophilia, 1998
Summary. At the end of the 20th century active immunization against hepatitis A and B has been introduced into routine medical practice. Therefore, patients at risk, and especially those with coagulation disorders, should be immunized at the earliest age possible.
C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, D. SHOUVAL   +5 more
openaire   +2 more sources

Viral Hepatitis Vaccines

2011
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire   +1 more source

Viral hepatitis: Global goals for vaccination

Journal of Clinical Virology, 2012
In countries where hepatitis A is highly endemic, exposure to hepatitis A virus (HAV) is almost universal before the age of 10 years, and large-scale immunization efforts are not required. In contrast, in areas of intermediate endemicity or in transition from high to intermediate endemicity, where transmission occurs primarily from person to person in ...
openaire   +2 more sources

WITHDRAWN: Viral Hepatitis: global goals for vaccination

Journal of Clinical Virology, 2009
This article has been withdrawn at the request of the author. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
openaire   +2 more sources

Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination

Current Diabetes Reports, 2016
Viral hepatitis has been posited to play a role in the development of type 2 diabetes. Thus, prevention of viral hepatitis through vaccination has the potential to reduce the burden of type 2 diabetes. We have shown that successful hepatitis B vaccination reduces the risk of diabetes by 33 %.
Rudruidee, Karnchanasorn, Horng-Yih, Ou, James, Lin, Lee-Ming, Chuang, Ken C, Chiu   +4 more
openaire   +2 more sources

[Preventive vaccination for viral hepatitis].

Zeitschrift fur Gastroenterologie, 1997
Viral hepatitis A-E belong to the most important infectious diseases worldwide. Viral hepatitis is highly endemic in most developing countries in Africa, South East Asia, and southern America; however also in industrialized countries as Germany hepatitis A, B and C represent a thread which should not be underestimated.
openaire   +1 more source

Viral hepatitis: 2. Hepatitis B vaccines.

Dental update, 1987
link_to_subscribed_fulltext
openaire   +2 more sources